Global Compound Sciences, Lead Generation - Discovery Enabling Capabilities & Sciences, AstraZeneca Pharmaceuticals, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK +44 0 1625517308 ;
Expert Opin Drug Discov. 2007 Aug;2(8):1103-14. doi: 10.1517/17460441.2.8.1103.
Modern drug discovery usually involves the rapid screening of large numbers of compounds, either individually or in resolvable mixtures. These compounds may be complex and lead-like or may be small fragments representing optimal scaffolds. Several methods are suitable for detecting binding interactions based on a wide range of different physical platforms. However, the use of thermodynamic measurements has a role to play both in the high-throughput identification of binders and also in the fundamental understanding of molecular interaction, which is central to rational drug design. This review describes the benefits and drawbacks of using thermodynamic characterisation of binding interactions at various stages in the rational drug design process and highlights future opportunities for advances in instrumentation and methodology.
现代药物发现通常涉及大量化合物的快速筛选,无论是单独筛选还是在可分辨的混合物中筛选。这些化合物可能是复杂的类似物,也可能是代表最佳骨架的小分子片段。有几种方法适用于基于广泛不同物理平台的结合相互作用的检测。然而,在高通量鉴定结合物和对分子相互作用的基本理解方面,热力学测量都具有一定的作用,而分子相互作用是合理药物设计的核心。本文综述了在合理药物设计过程的各个阶段对结合相互作用进行热力学表征的优缺点,并强调了仪器和方法学方面未来的发展机遇。